Evidence map›Paper›PMID 18988231›Full record

Trial reportCancer2008

Cancer patient preferences for quality and length of life.

Neal J Meropol, Brian L Egleston, Joanne S Buzaglo, Al B Benson, Donald J Cegala, Michael A Diefenbach, Linda Fleisher, Suzanne M Miller, Daniel P Sulmasy, Kevin P Weinfurt and 1 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00244868 (Facilitating Decision Making in Advanced Cancer Patients), which is not on this map. Cited by 98 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00244868 phase3completednot on this map

Facilitating Decision Making in Advanced Cancer Patients

TypeinterventionalSponsorFox Chase Cancer CenterRan2003Enrolled720ConditionsMetastatic Cancer, Unspecified Adult Solid Tumor, Protocol SpecificArmscounseling intervention, educational intervention
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population.Thyroid : official journal of the American Thyroid Association · 2020
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Patient preferences and travel burden before radiotherapy for primary cutaneous lymphoma: baseline results from the S-MISR registry.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  15. Article
  16. Article
  17. The correlation between pain and function in cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  18. Article
  19. Factors associated with health-related quality of life in survivors of childhood-onset and adult-onset cancer compared to controls.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Neal J MeropolDivision of Medical Science and Population Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. neal.meropol@fccc.edu
Brian L Egleston
Joanne S Buzaglo
Al B Benson
Donald J Cegala
Michael A Diefenbach
Linda Fleisher
Suzanne M Miller
Daniel P Sulmasy
Kevin P Weinfurt
CONNECT Study Research Group

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
PATIENT DECISION MARKING--PHASE 1 CLINICAL TRIALSR01CA082085 · NCI · FOX CHASE CANCER CENTER · PI MEROPOL, NEAL J · 1998 to 2007
$3.2M
NCI NIH HHS P30 CA006927NCI NIH HHS P30CA06927NCI NIH HHS R01 CA082085NCI NIH HHS R01CA082085NCRR NIH HHS UL1 RR025741
6 · The paper itself

Abstract

backgroundOptimal patient decision making requires integration of patient values, goals, and preferences with information received from the physician. In the case of a life-threatening illness such as cancer, the weights placed on quality of life (QOL) and length of life (LOL) represent critical values. The objective of the current study was to describe cancer patient values regarding QOL and LOL and explore associations with communication preferences.

methodsPatients with advanced cancer completed a computer-based survey before the initial consultation with a medical oncologist. Assessments included sociodemographics, physical and mental health state, values regarding quality and length of life, communication preferences, and cancer-related distress.

resultsAmong 459 patients with advanced cancer, 55% placed equal valued on QOL and LOL, 27% preferred QOL, and 18% preferred LOL. Patients with a QOL preference had lower levels of cancer-related distress (P < .001). A QOL preference was also associated with older age (P = .001), male sex (P = .003), and higher educational level (P = .062). Patients who preferred LOL over QOL desired a more supportive and less pessimistic communication style from their oncologists.

conclusionsThese data indicate that a values preference for LOL versus QOL may be simply measured, and is associated with wishes regarding the nature of oncologist communication. Awareness of these values during the clinical encounter could improve decision making by influencing the style and content of the communication between oncologists and their patients.

Indexed as

LongevityPatient SatisfactionQuality of LifeAdultAgedAged, 80 and overCommunicationDecision MakingFemaleHumansMaleMiddle AgedNeoplasmsPhysician-Patient Relations

Identifiers

PMID18988231
PMCPMC2606934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.